Jose R. Cortes-Ivorra
Valencia, VC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Guidance on JAK inhibitor treatment for inborn errors of JAK-STAT signaling, 2026: International consensus statement on behalf of the European Society for Immunodeficiencies/European Society for Blood and Marrow Transplantation-Inborn Errors Working Party and ERN-RITA.
Journal: The Journal of allergy and clinical immunology
Published: March 09, 2026
Guidance on JAK inhibitor treatment for inborn errors of JAK-STAT signaling (2026). An international consensus statement on behalf of the ESID/EBMT-IEWP and ERN-RITA.
Journal: The Journal of allergy and clinical immunology
Published: March 09, 2026
Giant cell arteritis-polymyalgia rheumatica spectrum disease (GPSD): Relation with neoplasms and possible role as a paraneoplastic syndrome.
Journal: Reumatologia clinica
Published: September 13, 2025
Clinical and Immunological Impact of JAK Inhibition in Concurrent Down Syndrome and STAT1 Gain of Function.
Journal: Journal of clinical immunology
Published: July 03, 2025
JAK inhibitors in combination with anti-TNF drugs on difficult-to-treat chronic polyarthritis: a case series.
Journal: Clinical and experimental rheumatology
Published: September 13, 2023
JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study.
Journal: The Journal of allergy and clinical immunology
Published: July 21, 2023
Efectiveness of belimumab in the treatment of lupus nephritis: analysis of 8 cases.
Journal: Medicina clinica
Published: March 28, 2022
Real-world Effectiveness and Safety of JAK Inhibitors in Rheumatoid Arthritis: A Single-centre Study.
Journal: Reumatologia clinica
Published: May 27, 2021
Disease Activity Indices in Rheumatoid Arthritis: Comparative Performance to Detect Changes in Function, IL-6 Levels, and Radiographic Progression.
Journal: Frontiers in medicine
Published: February 19, 2021
Last Updated: 09/26/2026